Renaissance Technologies’s Cogentix Medical, Inc. CGNT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2018
Q2 | – | Sell |
-1,005,137
| Closed | -$3.87M | – | 3712 |
|
|
2018
Q1 | $3.87M | Buy |
1,005,137
+296,500
| +42% | +$928K | ﹤0.01% | 1986 |
|
|
2017
Q4 | $2.23M | Buy |
708,637
+79,900
| +13% | +$230K | ﹤0.01% | 2283 |
|
|
2017
Q3 | $1.61M | Buy |
628,737
+69,658
| +12% | +$153K | ﹤0.01% | 2386 |
|
|
2017
Q2 | $973K | Sell |
559,079
-3,917
| -0.7% | -$6.72K | ﹤0.01% | 2564 |
|
|
2017
Q1 | $1.01M | Buy |
562,996
+12,459
| +2% | +$24.6K | ﹤0.01% | 2539 |
|
|
2016
Q4 | $1.11M | Buy |
550,537
+104,400
| +23% | +$213K | ﹤0.01% | 2506 |
|
|
2016
Q3 | $812K | Buy |
446,137
+109,474
| +33% | +$142K | ﹤0.01% | 2658 |
|
|
2016
Q2 | $324K | Buy |
336,663
+17,500
| +5% | +$17.3K | ﹤0.01% | 2926 |
|
|
2016
Q1 | $351K | Buy |
319,163
+12,600
| +4% | +$14.2K | ﹤0.01% | 2947 |
|
|
2015
Q4 | $395K | Buy |
306,563
+24,200
| +9% | +$33.1K | ﹤0.01% | 2806 |
|
|
2015
Q3 | $350K | Buy |
282,363
+23,600
| +9% | +$36.2K | ﹤0.01% | 2723 |
|
|
2015
Q2 | $419K | Buy |
+258,763
| New | +$424K | ﹤0.01% | 2775 |
|
Renaissance Technologies's CGNT Position: Q2 2018 in Review
Renaissance Technologies sold out of Cogentix Medical, Inc. (CGNT) in Q2 2018, closing a stake of 1,005,137 shares — an estimated $3.87M sold.
Renaissance Technologies first reported a position in CGNT in Q2 2015 and held it in 12 quarters. The position peaked at $3.87M in Q1 2018. 0 funds tracked by Wall St. Rank hold CGNT as of Q2 2018.
- Renaissance Technologies reported no remaining Cogentix Medical, Inc. position as of Q2 2018 after selling out during the quarter.
- Renaissance Technologies sold 1,005,137 Cogentix Medical, Inc. shares in Q2 2018, an estimated $3.87M.
- Renaissance Technologies first reported a position in Cogentix Medical, Inc. in Q2 2015 and held it in 12 quarters.
- Renaissance Technologies's Cogentix Medical, Inc. position peaked at $3.87M in Q1 2018.
- 0 funds tracked by Wall St. Rank held Cogentix Medical, Inc. as of Q2 2018.
Based on Renaissance Technologies's 13F filing for Q2 2018, filed 13 Aug 2018.